
- 积分
- 3
- 威望
- 3
- 包包
- 20
|
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
$ z# t6 Q$ @7 O- f3 L# ^# }2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷3 W' ~7 J3 Q8 j4 Y
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
/ j" J* {/ y, H. r8 L5-Aza:5-azacytidine,5-氮(杂)胞苷, |+ G: P4 a1 a: R
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
* f0 Q& Q8 e. F5 DAA:aplastic anemia,再生障碍性贫血
3 N, G' |. A0 F1 {AAV:adeno-associated virus,腺病毒相关病毒
! ^% x7 O c1 K, s5 ^Ab:antibody,抗体* P$ Y0 p( h5 o7 i
ABC:avidin-biiotin complex method, 亲和素生物素复合物法6 s# n$ V9 y+ S
ABMT:autologous bone marrow transplant,自体骨髓移植
- A" j3 J8 E. V# k% \5 u/ ]Ac:accessory cell,辅佐细胞& T# ~1 y4 F r
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
, r! Q* W' b: U* E4 vACP:acid phosphatase,酸性磷酸梅$ x, k$ l" f5 T' [- x
ACTD:actinomycin D,放线菌素D
8 E! r* B% k, p3 a5 P; sAcute:急性的 ' n) `4 y0 J. t6 \, u: v) K% k& }
ACV:cyclovir,阿昔洛韦
b+ F4 t, x( V) @. o. `2 Z* DAd:adenovirus,腺病毒
( M5 `& f& V2 t1 e, gAD:antigen determinant,抗原决定簇
) a+ p; j# D* {ADA:adenosine deaminase,腺苷脱氨酶
0 b" F/ m7 E# WADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性
- b0 f8 w; k l# KAdjuvant therapy:辅助治疗
2 l: m& J9 ~' cAEL:acute erythrocytic leukemia,急性红白血病5 O* d& s7 D, W! u% \
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病 W( Y3 |. `8 M2 t1 X' Q; {
AFP:alpha fetoprotein,甲胎蛋白
4 M/ \/ @% }4 W; _, e. d/ GAg:antigen,抗原
S0 M& f) J2 NaGVHD:acute graft versus host disease,急性移植物抗宿主病
2 W4 {8 `0 b. O3 y5 z5 O/ `Aid:anti-idiotype antibody,抗独特型抗体% Q% \ E4 h8 ~1 |
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
( s/ p% T# G, Z( `' f7 qAIF:apoptosis-inducing factor,凋亡诱导因子
6 T, G% K- X# ~$ v0 {9 U- OAIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血* A$ w4 q" t! q$ ]* H5 D
AL:acute leukemia, 急性白血病
2 n7 F: ~, f9 _ j m& ~ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤: A; e- h1 f* h- ~
ALG:antilymphocyte globulin, 抗淋巴细胞球蛋白( z" s$ v4 H% m8 x7 t& |" ~
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
/ W$ B4 {* b9 P W7 v* p0 {) ~ALL:acute lymphocytic leukemia,急性淋巴细胞白血病! j0 T. |; S) V$ i6 o9 l& p
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
- M% L/ l K# J: Y% HAllo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
" O* D0 C) Q+ N! T7 dAllogeneic:异基因的 # z4 v. w- z* C
Allograft:异体移植物
) P' d# ]' t7 F# p) vAlopecia:脱发& Z5 M' e1 q1 b, n$ D
ALP(AKP):Alkaline phosphatase,碱性磷酸酶3 {1 _% k: b2 m0 T# x5 p
AM:adhesion molecule,粘附分子
* r5 E# v+ [. ?4 [: r5 w) h* ZAMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
o( f/ t- H; m$ I- L! UAML:acute myeloid leukemia,急性髓性白血病
6 J9 y2 ?2 y7 K8 n3 n oAMM:agnogenic myeloid metaplasia,特发性髓外化生" N+ r! s$ U' k/ m5 {
ANA:antinuclear antibody,抗核抗体 ( h& |1 F. S( H: K; P
Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
5 [' D+ d6 b1 j- s- W$ D. FAnaphylaxis:过敏症: {" J6 ?) y4 }2 ]1 L6 t" ~. ~* T
" L' l4 G; F) T( J; }9 D1 wANC:absolute neutrophil count,中性粒细胞绝对值
# n) B! j& G* q* T/ pAnemia:贫血! U3 Z3 `9 b* a
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
- C/ y+ F( O, ]6 \2 p7 n- LAntibiotic:抗生素;抗生的 ; P/ ~$ `7 W& b2 ^6 F
Antiemetic:止吐剂,止吐药
5 E1 m6 o$ d- M5 I; d. M3 uantineoplastic drugs:抗肿瘤药物
# h3 W$ i7 W7 [9 b% gAntisense:反义引物! Q0 L, ~- \. s/ H: L* u$ P
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植2 `# N# u& d8 C/ |- u
APC:antigen processing cell,抗原呈递细胞! ^* m! A& E- r+ X; t+ |
Apheresis:血浆分离置换法,血液成分部分清除 6 z5 |' K6 q d, j! i9 A
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病
4 M4 E( U! K: b# z$ G/ C8 r4 ]Aplasia:发育不良,成形不完全
; F! F- q' s8 l5 U3 |5 EApoptosis:凋亡% t5 s6 z* @8 }/ h
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
, k- {( p3 c& H; a8 ^& v) z: ZARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
) M7 n+ v; p: i2 x- J: P5 WAscites:腹水 ; O2 a3 @ ^. d/ b% i& X6 U% D
ASCT:autologous stem cell transplantation,自体干细胞移植
; v9 g' t" x7 P2 e( U0 D# _* s, sAspergillus:曲霉属. c: A* q/ O% l; q$ C2 a
ASS:anterior superior spine,髂前上棘
: Y5 B6 f: V- j1 r4 YAT1257:nitrocaphane,消瘤芥
+ L% D+ E' n4 D7 t& ^ATG:antithymocyte globulin,抗胸腺细胞球蛋白9 a. \, l, V" ?9 y5 _
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤
" S; c' a+ T1 OATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
! w7 y2 U6 M3 Y7 u( m/ I: c7 }, cATRA:all-transretinoic acid,全反式维甲酸- i8 E+ P9 @% f3 f+ h: V
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病$ x0 Z& ~3 k6 y8 n3 [0 q
AuSCT: autologous stem cell transplantation,自体造血干细胞移植$ j% e' e4 v' H) i& r
Autologous:自体的 : G# W# B% l' ?6 L
Autograft:自体移植物
) a( C4 h4 X9 A; B3 \Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
1 A/ V/ `. z/ B' W. q mβ2-MG:β2-microglobulin,β2-微球蛋白% G3 i2 t |) L. x9 }
Back-up:备份/ ^) e' u, D0 N1 f
BCNU:Carmustine,卡氮芥,卡莫司汀! X s0 q- W+ }9 s* K6 e. S! R
BCR:breakpoint cluster region,断裂点丛集区: V/ ~/ { A1 r' x
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
; r1 f1 v/ _% x& e: ]# c( ^Biopsy:活检
6 d) R$ }5 u: F! ~ c( O7 n+ k+ yBlast cell:原始血细胞,母细胞
( T" P$ [; f- R: N/ nBlast-CFC:blast colony forming cell,原始细胞集落形成细胞3 Z' e# b% x; ~. w3 G
Blast crisis:原始细胞危象
% h, y) c2 x( vBm:memory B lymphocyte,记忆B淋巴细胞
H/ H2 A& q) V* x' cBMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病
- c6 M( A2 D4 S: wBMT:bone marrow transplantation,骨髓移植
- u( E1 V) W, W5 t0 h; iBone marrow biopsy:骨髓活检
. M5 X/ |9 u: h# RBone marrow puncture:骨髓穿刺! F' P. C5 a0 c9 o( {; J9 y9 ~
Bone marrow smear:骨髓穿刺涂片+ H9 W' w# k8 d& x, _9 ~3 P
BRM:biological response modifier,生物应答调节剂7 L* ~3 X# i' E8 d: g
Bu:busulfan,白消安,马利兰
2 l( s2 |" B" kBuffer:缓冲,缓冲剂,缓冲液7 l( q% }, b: i! _. ]
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原, [* g1 |# \' V- a2 X. ^
CAM:cell adhesion molecule,细胞粘附分子
& w& W, f. R' a9 f& OCandida:念珠菌属,假丝酵母属
l' D4 y9 @! \7 g9 ~; \1 MCatheter:导管
) t3 t3 v9 y; ]8 |0 lCB:cord blood,脐带血
# S/ C/ u% W! g! wCB1348:chlorambucil:苯丁酸氮芥
, s' C M( H0 _ V; i3 _CBC:complete blood count,全血细胞计数 " r8 m; y# x1 ~5 z! R5 l3 Y
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤& R: V3 q) Z8 Y2 b% V0 a
CBSCT:cord blood stem cell transplantation,脐血干细胞移植
+ \: f" b" q5 J- t% c3 Y) CCCI:corrected count increment,校正增值计数
! q. X/ _- |& WCCNSA:cell cycle non-specific agents,细胞周期非特异性药物 " h4 }% N5 m8 H9 O
CCNU:lomustine,洛莫司汀,环己亚硝脲
7 z X* a v/ s# sCCR:continuous complete remission,持续完全缓解
/ @1 L* T0 J( PCCSA:cell cycle specific agents,细胞周期特异性药物
$ N5 V$ l( I9 F' xCD:Castleman's disease,Castleman病3 h* ~+ P5 T9 T6 J3 b3 b5 F
CD:cluster of differentiation,分化群) d) q: l5 {* U" Q$ N# R9 w6 G
CD3AK:CD3 activated killer,CD3激活的杀伤细胞5 P1 O# }$ L+ F: d9 h }
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶8 J4 r& }! i \/ u
CEA:carcinoembryonic antigen,癌胚抗原9 n0 x; _+ P7 w, R; Y
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病5 `5 ^0 S L; D: `/ H
Central line:中心静脉导管,见central venous catheter.
2 j+ q8 _6 e3 c: W* B/ sCentral venous catheter: 中心静脉导管,又叫做central line,Hickman catheter
5 l+ z: e: ~6 zCentrifugation:离心
; u- F. ^& B+ ]7 Y( b: RCFC:colony-forming cell,克隆形成细胞+ D3 J! F8 I/ X! ]( Q- v
CFU:colony-forming unit,集落形成单位' R* Z* u9 e$ m
CFU-Blast:colony-forming unit-Blast,原始集落生成细胞
9 L; E7 i/ W) lCFU-E:colony-forming unit-erythroid,红系集落生成细胞
: ]9 `, ?3 O; J ? G5 G1 KCFU-G:colony-forming unit-granulocyte,粒系集落生成细胞/ Y' s( u, R, Z( ~
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
2 S8 v; w0 R0 c* a! d9 iCFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位9 s5 e( n$ r8 O; w% T
CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞: y" t- y; m- n3 m' v1 X% w$ O
CGD:chronic granulomatous disease,慢性肉芽肿病
3 \% d5 [. `: m8 v6 UCGP:circulating granulocyte pool,循环粒细胞池8 A3 l' w, U4 u; ~" ^* j5 G
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病
$ x* R# V/ M+ q `7 YChemo-responsive:化疗敏感的 : H9 Q4 ]9 ?- A8 B& X: }9 [- ]1 I
Chemotherapy:化学疗法 ) K/ G! Z/ j" a/ C8 D
Chronic慢性的 0 G! ~ R/ l: n" c) ?
C.I.:continuous infusion,持续静脉点滴0 K% }1 o1 M. m. v: [% p1 k% t
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
6 f% F5 r, K1 H$ P3 S) ~6 ?. QCliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
( E0 H3 m0 Y( T% X( u; nCLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病% ^6 R: F3 ~4 \: W* t/ R: U
CML:chronic myelogenous leukemia,慢性粒细胞白血病) A2 @" X) L+ G. W
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
" Y8 u5 b: l, O" JCML-BP:CML-blastic phase,慢性粒细胞白血病急变期
$ W( ]1 i3 Q/ L8 ]CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
, I/ Q! ]/ F, d" o& ?( g/ D9 h1 ?CMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
9 g1 ^' y: [" C# R3 F- @CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
& V: X" C0 k+ _7 m5 CCMV:cytomegalovirus,巨细胞病毒8 M, K; g. I+ ~2 m2 E/ x8 v2 \' d
CNR:cytokine negative response cell,细胞因子不反应细胞0 }2 L: V* r7 I: S$ A# D' G0 h
CNS:central nervous system,中枢神经系统2 v- S' n# Q$ }# @! h4 W, G4 S2 e
CNSL:central nervous system leukemia,中枢神经系统白血病* V4 _: E1 I U; T: j0 F
Collection: 采集# ^1 Z# L- ?! n# Z: E
Colony stimulating factor:集落刺激因子 9 C+ l5 H. u# A
c-onc:cellular oncogene,细胞癌基因* c( q1 q# v$ J. c4 J3 W; u) w
Conditioning:预处理
1 f0 m( k+ m: t# f9 QConjunctivitis:结膜炎
# S' J- M: @4 S9 v& ?Convalescence:恢复,恢复期! w7 k D( R$ w* M% t
CP:cancer procoagulant,癌性促凝物质
& g2 @" P8 q6 A2 a& R! m, NCPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖
0 f+ V/ Y6 e) gCPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤: Q6 ~" J1 ]1 g4 R! ^
Cpmax:peak concentration,峰浓度2 q/ x/ p; {/ ^( z A( S! ]
CPT:camptothecine,喜树碱
# V3 k. g2 [9 V7 a: f+ {- a* [. MCR:complete remission,完全缓解6 G' |5 @3 J; M, J% u1 l- R+ r
CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
9 i( E4 P; W/ TCRP:C reaction protein,丙反应蛋白 ' @2 i h& K0 H e# B9 \
CRR:complete remission rate,完全缓解率, ^+ n1 p2 Y/ ^' e+ u
Cryopreservation:冷冻保存,深低温保藏 % X! I' r) `$ M% L3 G2 [; ]
CSF:colony stimulating factor,集落刺激因子8 t6 z3 r. @' J( E! |
CSF:cerebrospinal fluid,脑脊液
& s, F- n. g# }, z' c% }4 yCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤 [4 w" S) h6 `
CTCL:central T cell lymphoma,中枢T细胞淋巴瘤9 A3 m! g" ^- G- Y0 F
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
# J. t* k, ^8 A" n' c/ mCyclin:周期素5 V! X% ^: j; g' _. i
Cytomegalovirus:巨细胞病毒 : U2 U/ |4 `5 X9 I* U& \) D
DC:dendric cell,树突细胞$ n6 @5 W; `9 C! t/ i/ e, I
D-D:D dimer,D-二聚体/ _. k P7 y" R9 L
Del:deletion,缺失# W* n6 b ~' _1 C
Dermatitis:皮炎
) X/ s, X6 j2 ?8 |6 iDe nova AML:非继发性急性髓性白血病 1 o! d1 Q7 l7 I4 \' G+ t9 A+ n) K
DFS:disease free survival,无病生存期
- E7 N# I% S( x+ qDI:DNA index,DNA 指数
! S4 V7 a$ L' {& {DIC:disseminated intravascular coagulation,播散性血管内凝血
- k, {8 t0 F9 D0 LDilution:稀释
1 f7 W* G4 @6 W' {DL:discordant lymphoma,混杂型淋巴瘤
. ~! N: I7 ^ M. [$ {7 H* r! {5 [Donor:供者
9 N% U' T- _8 A# F. PDysplasia:发育不良,发育异常 + B5 k y( L0 j i# @
EBV:Epstein-Barr virus,EB病毒
3 i" \5 ]2 R+ c/ f! e; s. FECM:extracellular matrix,细胞外基质7 m! G/ _) j& w8 I/ m( S, l0 l- R
-ectomy:(后缀)(外科)切除,除去,去掉 / V. G& a' G; c
Edema:水肿 . J! n& J3 e+ r, X d G
EGF:epithelial growth factor,表皮生长因子9 I C! t$ G9 Z3 K5 P2 Q
-emia:(后缀)血液疾病 ! Q/ k7 F0 t: @% u5 M
Encephalopathy:脑病
% L" n9 N. x1 S2 \' ]& {* SEncode: 编码2 I5 n4 i& p+ p0 L
Engraftment:移植物植入
5 Q1 L* K/ |1 J- o3 vEnrich:富集
# r& m; t h; r- o" w$ bEnzyme:酶
# [: R: a Q0 L- i+ e8 IEosinophil:嗜酸性粒细胞2 I f1 z9 O, K; O' C0 u
EPO:erythropoietin,促红素,红细胞生成素6 Y7 x! I0 {& t8 f
ETT:essential thrombocythemia,原发性血小板增多症
; e/ ]6 n& O. m# e8 x/ |( x3 c$ KEx vivo:体外 , Y2 [' U: w' @# [
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统; Y5 _3 x3 Z9 |$ i$ n0 [
FCM:flow cytometry,流式细胞分析技术+ u5 `; V7 b" c# { b$ ]* f5 t
FDC:follicular dendritic cells,滤泡树突状细胞
% X, Z" w: p* _% B. o$ s3 Z3 LFDGF:fibroblast derived growth factor,成纤维细胞源生长因子
c$ I9 z0 x9 ^: YFebrile:发热的 % S! L' Y+ J2 P; j7 ?8 Y! i1 |
FFP:fresh frozen plasma,新鲜冰冻血浆; \8 v; O# Z4 `; [
FGF:fibroblast growth factor,成纤维细胞生长因子
. Q9 l! `: x" }7 L, t* MFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症
6 o4 h" f$ h. H5 o# m- [FISH:fluorescence in situ hybridization,荧光原位杂交
, H& Z/ D, `4 x' NFMF:familial Mediteranean fever,家族性地中海热' b* Y: | { [# ~* |0 ^
Foley catheter:弗利氏导尿管,气囊导尿管 8 c( m9 Q& @9 b% ]- A
FrTBI:fractional total body irradiation,分次全身照射6 f4 c3 x6 n3 R" u$ S( ?2 |! [8 F! ?1 L0 F
FSRC: 胎羊体内增殖的人造血干细胞
- L% o6 I- W4 l SFungus:真菌 ; C4 O3 X, N, s7 {% X; G
Fungi: Fungus复数形式% ~ h& _. ^( U+ w8 Y
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
* f& }6 L9 R1 }$ m5 P+ FGastritis:胃炎 3 g' S: |5 }- {% r8 z2 h
Gastrointestinal:胃肠道的 3 N9 ]* y. }9 s0 |
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
' C$ A6 Q1 T) p7 _' HG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子 " k4 ?$ b) r7 k5 p8 Z3 h3 N
GCV:cytomegalovirus,巨细胞病毒) Z+ B8 K b1 S! l! R/ i- C0 B2 R
GCV:ganciclovir,更昔洛韦8 N& S" O) s8 h% X' R, e
GI:gastrointestinal,胃肠道的
6 f5 a; M- B) l6 kGM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
8 V( X- T7 U WGM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞3 p1 C7 r% {, [
Graft rejection:移植排斥(反应) ; e9 e7 Y/ o& _, f- t& \0 x
Graft-versus-host disease:移植物抗宿主病
4 d8 |; f1 g# y" q3 n) X$ SGranulocyte:粒细胞
; n5 A$ z/ c+ L. N, d6 x! b2 fGrowth factor:生长因子
9 b7 r* T. ]1 V' M0 l1 hGTR:granulocyte turnover rate,粒细胞转换率0 E0 @0 E# }; W2 i2 h
GVHD:graft-versus-host disease,移植物抗宿主病 - {/ m( ?1 L/ ?" ~8 ]2 n- Y, F- q
GVHR: graft-versus-host reaction,移植物抗宿主反应
" \- P/ e2 O4 j0 NGVL:graft-versus-leukemia,移植物抗白血病5 ]- {6 z+ C: q
GVT:graft-versus-tumor,移植物抗肿瘤
6 v8 l; q2 R! \/ v" q$ G1 x+ wHaploidentical: 半相和的
A. ?2 Y' \6 D& q; a" FHarvest: 收集,采集) V2 }$ w4 k* l
HC:hemorrhagic cystitis,出血性膀胱炎5 F3 ], \: S# i# V
HCL:hairy cell leukemia,毛细胞白血病( d/ A% a) S* d7 P t
HD:Hodgkin's disease,霍奇金病
" B+ a: @4 q$ u( jHD:high dose,大剂量
0 s" {6 m4 f% L" j+ [7 `# y* lHematocrit:红细胞压积
% P8 L" h+ }# q- ?6 w, X4 kHematology:血液学
* s: K( H- M( F6 A4 _& S/ `/ QHematopoiesis:造血作用,生血作用
5 \; Z8 V) q* z! B& k" K. X# ]Hematopoietic system:造血系统
4 C, V! P, P' }, hHemoglobin:血色素,血红蛋白 e( v" E3 Z5 q b* v. B* H; L
Hemorrhage:出血 ; ?8 x ~ f& d! H
Hemorrhagic cystitis:出血性膀胱炎
8 \3 {# H* G k/ YHepat - :(前缀)肝的1 @6 q1 t) k" t2 ^. B6 i
Hepatitis:肝炎
6 i3 I' y1 Z+ X$ LHES:hypereosinophilic syndrome,高嗜酸粒细胞综合征9 Y1 W* o/ g! W
HGF:hematopoietic growth factor,造血生长因子# O! x+ c A( u! t# \; c
HHV:human herpus virus,人疱疹病毒
' N; j! X$ E2 LHickman catheter:Hichman导管,中心静脉插管 9 y! d m) A' f% l4 E& u; c5 X
HIV:human immune deficiency virus,人免疫缺陷病毒; |+ |! n# w- ^8 V
HLA:human leukocyte antigen,人类白细胞抗原
" l" r( s% \( nHLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
. I0 `9 H" G: k/ w4 J1 wHMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
- p$ i. z9 C& w5 P8 _7 s XHomogenic transplantation:同基因移植! T* y: y% o Z1 f
Homozygote:纯合子
o7 |2 m, l' R9 `HPC:hematopoietic progenitor cell,造血祖细胞
, [; X, l$ p7 O0 ?# e3 ]7 V$ iHPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位- b, T; e0 k. [% G" q
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病) `# f7 G( V6 I- U: W
HSC:Hand-Schuller-Christian disease,韩-薛-柯病
( X& u: H7 J/ A( o' r" NHSC:hematopoietic stem cell,造血干细胞0 W9 t& F. f/ y/ _- L7 W& ^! C$ G; ^# \5 O
HSR:homogenously staining region,均染色区
" D( f$ z7 x1 d& }0 P2 E* r7 L7 AHSV:herpes simplex virus,单纯疱疹病毒
& T; n2 {4 t9 x* J N z+ H8 yHTC: typing cell,纯合子分型细胞( U2 _6 \& C: K$ p# I- \
HTLV:human T cell leukemia virus,人类T细胞白血病病毒
( P! ?; v/ e( w" A/ z: eHVOD:hepatic venous occlusive disease,肝静脉闭塞病
9 X) M+ Q. b# @# DHyper- :(前缀)高,超,(过)多3 u, W/ N9 E1 J& [) u
Hyperalimentation:高营养支持,静脉高营养0 P: c5 p ^, p- ~6 k
Hyperpigmentation:色素沉着过度 & `/ t% o2 t% C: a X6 P
Hypertension:高血压
% l, O/ w& j4 H) k9 _* O( S7 _Hypo- :(前缀)(过)低,少于; P" D/ h# }$ g3 j9 J+ V9 ?
Hypotension:低血压
$ i) z& u. q; V. D- C1 rIAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
) D; _4 D8 ?( k1 o5 {id:medium dose,中剂量$ t) R, ]- j) v3 e* \. L
id:initial dose,初始剂量
2 l& O, T$ `, ]) rIF:involved field,累及野
) j# i8 e( ?7 jIFN:interferon,干扰素, Z- h) U1 Z3 C- Y7 M1 s/ x
Ig:immunoglobulin,免疫球蛋白
' P/ T u8 ]# i1 iIGFs: insulin-like growth factor,胰岛素样生长因子
0 d8 a" Z. S. dIgH:immunoglobulin heavy chain,免疫球蛋白重链
1 E4 a1 S2 g7 f) z8 i; J, {IL:interleukin,白细胞介素
. Q4 u4 u2 W' f* V& n. mIliac crest:髂嵴 ' g: p6 U, M7 R. B4 R% V, L% o
I.M.:intramuscular,肌肉注射
5 |; H/ K0 E4 |' q& F; e: u3 S& tImmune system:免疫系统 1 B& |2 w: l; z( x6 r9 z
Immunocompromised:免疫受损的 * N5 I' }; v; U' v; L' D: L; ?: T
Immunoglobulin:免疫球蛋白 , Z( d6 N% B* w+ Y" ^, o
Immunological tolerance:免疫耐受
; x1 [$ N. _8 I+ C, c( CImmunosuppression:免疫抑制 1 Y/ J; k9 C4 ?* d% }7 O+ S T) B% n
Incubation:孵育( z4 H1 W B9 ]% ^! i9 _$ G
informed-consent:知情同意3 e4 Z0 ?5 z* y! q: z% D
Intravenous:静脉内的; O ]- b( p$ q0 r2 h l8 d6 M6 r
inv: inversion,倒位/ m% D& G1 j% b0 ]/ `$ ~
in vitro: 体外,离体
5 p, n9 h- G) hin vivo: 体内$ W/ l T( s" u3 W2 m0 @8 A8 \, t
IP:interstitial pneumonia,间质性肺炎
; {" p0 S3 g7 S x8 H5 c+ DIsolation: 分离
# a2 l7 H# H# u; u: QI.T.:intrathecal injection,鞘内注射$ x9 W- R7 o7 S+ ~- n( s; ]2 E
-itis:(后缀)炎症 2 p7 X0 Z/ q( J6 I9 `5 v$ B: L4 b
ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
) h7 e; C, z& [4 s; U' l( pJaundice:黄疸
* l* D5 f5 z2 l1 q3 m+ u6 [KPS:Karnofsky score, Karnofsky评分3 h- k! K* G9 n' k F
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)3 k7 v0 }2 r) h$ s% R. J
Laminar air flow unit:层流间
+ p) ]. Z2 c1 nLCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症5 a( r/ }) `" {0 [. @2 F
LD:lymphocyte depletion,淋巴细胞消减型$ | }( Z W+ T! R. m" }6 p
LD:low dose,小剂量
8 v" k- |0 M- x$ _9 h' b: p- k1 F0 ^LDH:lactate dehydrogenase,乳酸脱氢酶
" ~! b. ?" [2 A$ @: n. qLeukapheresis: 白细胞采集物6 K7 b; _+ b; W* O- f* [! b7 @* ^
Leukemia:白血病 ) C+ [" k- H, D G
Leukocyte:白细胞
3 u. Z. B7 A M4 T) P9 \9 s7 I" rLeukopenia: 白细胞减少症: y8 ?7 R# M% U2 N" s7 `: k
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 2 [$ i+ E/ f+ F9 Z% }
LFS:leukemia free survival,无白血病存活期6 I7 w: x- S8 _+ k+ M+ ]
LGL:low grade lymphoma,低度恶性淋巴瘤# N7 i( G: ~) I3 A! [
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体+ y2 c6 F' N9 E5 x
LI:labeling index,标记指数
. y& }- |/ x* @% Z1 fLIF:leukemia inhibition factor,白血病抑制因子
2 D! k0 n: V9 l( U) BLineage:系. r. a, D0 u3 [7 {5 v& J
LOH:loss of heterozygosity,杂合性丢失
# V7 H p7 u g& |LP:lymphocyte predominance,淋巴细胞为主型
" x9 _8 m. W( E4 y- S* i! DLRP:lung resistance related protein,肺抗性相关蛋白
; _0 b1 v6 U2 n: x0 r$ s" iLTB:life-threatening bleeding,致命性出血
2 X7 s) P3 F3 t3 Y1 ?) n8 y7 K5 L& @; ^LTC-IC:long-term culture-initiating cell,长期培养起始细胞* R7 a' {; [9 s8 X
LTR:long terminal repeat:长末端重复序列9 H/ {$ e0 a% p, ~1 l
LVL:large volume leukapheresis,大容量白细胞单采
) ?7 g& ]6 V/ ~: TLymphocyte: 淋巴细胞) ~8 v1 J5 G6 R
Macrophage:巨噬细胞
+ }0 E5 ]. C7 R' u: c- ZMACS:magnetic activated cell sorting,磁性活化细胞分选
; i1 _. `% O+ U' G- s" ZMAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
8 Z8 z* x: r: u: W7 L6 K) }6 pMalabsorption:吸收障碍' e6 ~2 n+ b# ~4 e& z3 N, j. ^" p; h
MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
* M/ d6 a7 y( G; r; s0 wMatching:配型# P |6 u0 E" d
MBDI:marrow blast decline index骨髓原始细胞减少指数
+ B5 D+ q8 B dMC:mixed cellularity,混合细胞型
@3 g& i! |) M+ `- U; O" eMcAb:monoclonal antibody,单克隆抗体
) S4 p; f4 W# }1 F5 V! omCR: median complete remission,中位完全缓解 * b+ G/ b8 l6 q! |1 D8 E
MDR:multiple drug resistance,多药耐药+ }) ?$ u; b% y) W
MDS:myelodysplastic syndrome,骨髓增生异常综合征
& e4 ~9 @1 M. r- M: U6 XMegakaryocyte:巨核细胞
- B8 h' l0 e' V! M' ~1 TMetabolite:代谢物 % }) A! N1 _1 m7 {
Metastatic:转移的 5 I) G" C7 T% d; o
MF:myelofibrosis,骨髓纤维化
0 r4 M1 k. f6 Y) N Y( eMF:mycosis fungoides,蕈样霉菌病5 ~" s; _ t1 X) q- E7 w3 |
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
: }2 o$ z& v2 eMGP:marginal granulocyte pool,边缘粒细胞池
1 n8 Z/ W6 U3 e% jMGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症1 k. o6 j1 G; g$ Y: ]
MH:malignant histocytosis,恶性组织细胞增生症
0 ]$ Q3 \# d2 D) P; V! |MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
8 t3 u3 A" W4 S3 }8 _MHC:major histocompatibility complex,主要组织相容性抗原复合体$ X, q$ w6 B/ a. Q! {+ T H; F* I
MLC:mixed lymphocyte culture,混合淋巴细胞培养 ) y3 Y2 ]0 m$ J
MLL:mixed lineage leukemia,混合系白血病
$ o+ N' B& l" V; EMM:multiple myeloma,多发性骨髓瘤1 O; \5 L T g2 Q; T
MNC:mononuclear cells,单个核细胞
/ p' x) u. P& F! t5 LMobilization:动员5 g, u% I' ]) u' R X
Monoclonal antibody:单克隆抗体 + l2 Q2 l" E5 P5 o* l+ Y9 E' u
Monocyte:单核细胞
' N1 V. t- B3 Z. Z3 e3 {7 XMonozygotic:单合子的
# L: d ^4 r! u' I! O1 X" R& w; HMorbidity:发病率
( y; O# e" x* X9 k) q& e! Q; Y3 N, H2 ~MPD:myeloproliferative disease, 骨髓增殖性疾病/ k; D! {2 h7 v/ C$ S7 ^
MPO:myeloperoxidase,髓过氧化物酶. L4 C j2 d9 [% D5 A& b4 [3 X) u
MRD:minimal residual disease,微小残留病变 5 J, l. z7 L# R. R7 o
MRP:multidrug resistance-associated protein,多药耐药相关蛋白
! b% D5 E6 K* l, H3 VMucositis:粘膜炎 $ a$ z# q% y$ o2 S# `
MUD:matched unrelated donor,非血缘关系配型相合供体7 O. [/ D9 `6 G
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶" N$ S7 S: u& H: j' S
NB:neuroblastoma,神经母细胞瘤
2 { {0 \/ ?, ~2 t+ } d+ sNBM:normal bone marrow,正常骨髓
+ g5 N- _) _& Y* V, \$ cNegative selection:阴性选择$ h' @; H8 u1 k* J; I3 [" L' P
Neuro- :(前缀)神经的
1 V3 n6 m4 X4 vNeutropenia:中性粒细胞减少症 , j [/ C$ D, a1 Q: p
Neutrophil:中性粒细胞 1 T$ T3 R6 s( @7 T' p; L0 ~" N
NG:neutrophil granulocyte,中性粒细胞
6 K2 J" \/ y% L- Q9 A: N' SNGF:nerve growth factor, 神经生长因子8 Z* C+ @4 u" E5 o
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
& E: \0 K; ~5 g7 `2 T6 ~NK: nature killer cell,自然杀伤细胞
% ?. t" J8 ^4 F1 h. q3 vNonmyeloablative transplantation: 非清髓性移植) Q; X) B5 P9 p c1 E# q
NPO:不能进食 , p8 o/ b6 p7 ~) L# [, t
NS:nodular sclerosis,结节硬化型 / }9 i/ I1 f8 p1 k; X0 F6 s4 ^. \
Oncology:肿瘤学 4 ^, t1 E3 C7 n4 ~* R! {2 y, J
Oto- :(前缀)耳的
& V$ F; M* x- T, l) w9 IPA:plasminogen activator,纤溶酶原激活物
& L* r( r- k9 Y' z( w( \; N: s4 BPacked red blood cells: 压积红细胞 f" L* T3 n; E, z) p& `
PAE:post antibiotic effects,抗生素后续作用8 ^) p6 W! N/ F) r: Y0 G; S
PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂" T7 C. `# l c+ ~7 ?; i. |; ^6 X
Palliative:减轻的,缓解的 1 J/ m5 V" s2 ]; [
palliative care unit (PCU):终末期病房,临终关怀病房1 k! K t- \ m/ |5 [# h
Pancytopenia:全血细胞减少症
; D B7 f V6 V-pathy:(后缀)病 f+ e7 C5 v2 u6 x% g4 N1 W0 {9 `7 o i
PB:peripheral blood, 外周血
- {8 b; \$ r! N; r$ z7 ePBL:peripheral blood lymphocyte,外周血淋巴细胞
2 k1 s$ {+ x* g3 ^6 @. X: ?PBPC:peripheral blood progenitor cell,外周血祖细胞
0 Q! c. Z9 @. w2 C7 ]! q: APBSCT:peripheral blood stem cell transplantation,外周血干细胞移植
9 T$ p8 s6 f" APCA:procoagulant activity,促凝活性物质
! P& }$ x- L1 f) t$ gPCD:programmed cell death,细胞程序化死亡; g- H" m' E' C; d- C( r4 v F
PCL:plasma cell leukemia,浆细胞白血病
7 A3 i6 P! J% m3 V4 ~- `" [PCLI:plasma cell label index,浆细胞标记指数
6 h; e- J- p8 D3 R6 K9 WPCR:polymerase chain reaction, 多聚酶链反应
- U& q# }7 D5 ?; fPCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析8 e. G" a& p1 h9 c, F% F4 D$ K
PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交" [7 p/ n# y. w) D, i2 s, {# d
PDD:percentage depth dosage,百分深度剂量( c- x: N* b# q9 P# P0 ^9 v1 B9 m2 }
PDGF:platelet derived growth factor,血小板衍生生长因子4 l- H! B$ ]9 |: i* ^! v9 C
PDR:primary drug resistance,原药耐药
! t: Y* @" G" I8 H! GPE:plasma exchange,血浆置换; `- ?" I. w) p( b% a) G' O! B% T
-penia:(后缀)缺乏,不足 " o8 v$ u" l) [$ P
Peripheral neuropathy:周围神经病变
# ~, m& V% f+ b/ R9 `8 q ePetechiae:瘀点,瘀斑 $ T- |8 V3 g$ j
Pfu: plaque forming unit,空斑形成单位4 _3 f) w7 L) x9 ]- k
PHA:phytahematoagglutinin,植物血凝素
2 ^" l& r9 R* r/ J, v+ zPhlebitis:静脉炎 % |( C. V3 \4 o( ]
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
) { s/ y9 e7 A2 T0 L-plasia:(后缀)发展,形成
; _# f* ^: U6 z- L( qPlasma:血浆
) h, o& n4 S9 }. x, pPlasma cell: 浆细胞 % T- L( s6 e, `7 A1 W0 \% L+ I a4 }
Platelet:血小板 7 m2 b8 W, @* a) O! N8 B( e$ [, R) {8 M
PLG:plasminogen,纤溶酶原5 m6 A ?8 o+ p* o. S, ?( a
PLL:prolymphocytic leukemia,幼淋巴细胞白血病
0 C9 S. s- R* @7 ^+ KPLT:platelet,血小板& j$ g' x0 T; L, T2 k4 b
PLT:primed lymphocyte test,预致敏淋巴细胞试验
2 N3 }. B4 T+ T2 q- [PMN:polymorphonuclear leukocyte,多形核白细胞1 ^2 j2 V1 t, j. \4 b1 M3 i" ~
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
2 G Q- D ?3 W. i' TPNRE:p53 negative response element,p53阴性反应元件
+ p& a* u9 v" g9 X' ~* b# YPOD:PML oncogenic domain,PML癌基因结构域
* `* t8 Q- F$ D- \2 E: wPolycythemia:红细胞增多症 ) ?: @; w3 b/ q
Positive selection:阳性选择
, Q1 Z; Y8 A8 Z UPPSC: pluripotent hemotopoietic stem cell,全能造血干细胞
7 ?4 ~1 L" ]. E, m4 {, z% yPreparative regimen:预处理方案
) R4 J/ Y' n* T9 G2 W; MProgenitor:前体,祖先
* B3 ^, z3 ~! NPrognosis:预后
1 K. k( \ a) E$ OProphylactic:adj.预防的;n. 预防性,预防药
% N) v: f& S( O9 ~8 z* B. DProphylaxis:预防法,预防
; b! U* ]; ~: {& w1 yProtocol:草案,协议,治疗方案 " Z' n8 s7 q) f) V9 S8 V& @
Proto-onc: proto-oncogene,原癌基因
9 j+ q' o+ W& H9 KPSS:posterior superior spine,髂后上棘
9 h( X- e; {; H1 v" {: F9 N+ MPT:prothrombin time,凝血酶原时间% W) D; F7 k& C: j8 I# U
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
* {0 n: i* u. k, y b* QPTH:post-transfusion hepatitis, 输血后肝炎% p. q# s/ p7 [/ n" B
Pulmonary:肺的 8 g( [, [7 Z( o' s) j! r
Purging:净化
+ B3 [( d. M4 _! D! c; i3 |8 v9 |3 QPurity:纯度* ?( A7 t! h; f0 h: R' o
PV:polycythemia vera,真性红细胞增多症% ~6 ?/ c" [# u( y
Quality of Life (QOL):生活质量
( k- I5 p0 C0 F# |) CRA:refractory anemia,难治性贫血 3 e3 y9 ]" Y1 c3 a" T. k
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型$ D. H/ W3 y! z) d! d
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
h% e% D- b6 ~* X, s$ X2 }2 IRAR:retinoic acid receptor,维甲酸受体9 E2 G% G( O3 s/ K. |
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多4 q6 p, z- c r% l& M; c: s9 X
RAS:retinoic acid syndrome,维甲酸综合征4 o7 h+ G# ]5 e$ n H3 H5 P, X
RB:retinoblastoma,视网膜母细胞瘤
' I4 }7 R& Y! O( ~: Z! SRBC: red blood cell,红细胞
- H* e9 T( P% v' `$ gReagent:试剂2 n3 M; Y" F m- p
Recipient:受者
+ _; u$ C8 c7 Z1 ^% z& S* ^- r( `Rejection:排斥
/ T$ P: [% E4 K! H7 T& U! k, \Relapse:复发
) e7 L: t+ v0 R( W: V0 o; |Remission:缓解 5 w! D$ F A3 ]; s
Renal:肾脏的,肾的 2 q% O* N; ^/ T5 F& L" A: I4 h
RFS:replase free survival,无复发生存. I) ?4 {2 v# a8 _3 j4 G
RPC:radiation protective competence, 辐射保护能力
9 ~0 _" X8 y s, A, V1 GRegimen-related toxicity (RRT):预处理相关毒性0 P6 O: a& A2 D2 o& q6 R+ F
RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
0 n7 w7 X; B- J* OSBB:sudan black B,苏丹黑B2 }- E: I' \: D# E/ H; _
SCE:sister chromatial exchange,姐妹染色单体交换7 u# M" e/ ]6 q6 R
SCF:stem cell factor,干细胞因子
& X+ G5 @% a+ @2 NSCid:severe combined immunodeficiency disease,重症联合免疫缺陷! x C" J" d0 n2 @9 ?
SCL:stem cell leukemia,干细胞白血病/ J) Q# |! }( o! G% X4 A
SE:specific estarase,特异性酯酶
5 ?) ]; ~$ y$ g1 l! y$ L( \5 m$ I+ OSelectin:选择素. G) V& g- {8 [/ }% a2 B, j4 ]
Sense primer:同义引物% ]& A2 [5 e# }
Separation:(细胞)分选
+ p* I5 y$ r; A& ~Sepsis:脓血病,败血病 ' E, _6 y# k$ T3 ~+ E" k0 U/ g5 p
Sequencing测序
, t5 f* C6 C0 l! u) z9 PSF:serum ferritin,血清铁蛋白
0 }# w8 S7 d3 O) P% xSHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大
6 O9 q: [& v: BSIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法
4 f( S* }! S+ a3 W1 @' ^+ W* ^7 L7 FSLE:systemic lupus erythematosus,系统性红斑狼疮3 P0 ?8 k, j, v1 L$ \5 v6 z
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
6 \- G6 f3 f8 B3 l$ YSolid tumor:实体瘤, x& G6 l% x. V3 I' S- V: T! w8 q
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
( z) ^1 n) p( v) E& _4 eSRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
1 p6 v, P$ R* ]SS:Sezary syndrome,Sezary综合征
( d+ ]/ B, R& iStem cell:干细胞* ]( `9 s9 K+ b$ R# F8 O; f
STNI:subtotal nodal irradiation,次全淋巴结照射
0 D. L% X% j& v) p; E: MStomatitis:口炎 % V! M+ b2 G3 c7 [& g/ G
Subclavian catheter:锁骨下导管
. \$ f# |" {& v0 rSupernatant:上清
$ g# i% t/ D. e! J, Z; u, X- }7 s# ISyn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 $ j8 X3 M- i4 ~2 W: S
Syngeneic:同基因的
. }% q* r2 O3 Z1 n6 vTAM:tumor associated macrophage,肿瘤相关巨噬细胞- m+ z% U. {$ y- M' l5 f
t-AML:treatment associated AML,治疗相关的急性髓性白血病
; |0 C! b: t' V+ q. E2 KTA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
# K( n4 k0 W8 c4 S5 I4 nTAA:tumor associated antigen,肿瘤相关抗原
4 j: m0 G; W) H1 ?& S9 D- a9 CTBGP:total blood granulocyte pool,总血液粒细胞池
2 M8 F% b- Z, b2 a7 oTBI:total body irradiation,全身照射
0 o6 i S" R3 \0 F1 J" `' z; VTc:time of cell cycle, 细胞周期时间
7 U1 D- f; a! E# t+ I$ |TCD:T cell depletion, T细胞去除- Y6 ]0 h& L4 ~$ D# `7 u
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤 7 \ o' ]+ F. e6 m3 Y- V
TCR:T cell receptor,T细胞受体$ h. l& j! X6 A3 S' H& l) y
TCS:tumor cell survival,肿瘤细胞成活5 l0 W6 Y6 g" A- |4 g; ]3 ^7 \3 R
TEN:total enteral nutrition,完全胃肠内营养$ Z; V1 O6 |8 K9 v7 J' D
TF:tissue factor,组织因子
; |( k3 e2 M: u8 E" w, [. |TF:thymic factor,胸腺因子# z- e* b( r( k* H: x* U) y
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物
* _. A3 N+ p* q4 d4 ETGF:therapeutic gain factor,治疗获得系数
3 _( }& `) |8 u8 V# {0 K" ]TGF-β:transforming growth factor-β,转化生长因子β
+ b! C# i8 k9 k6 p! `7 }. SThrombocyte:血小板
( \# d" a$ y3 ~" h# ^Thrombocytopenia:血小板减少症
" L7 a8 g& N6 U3 k# MTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞
5 Z& \/ v) V; GTL:testis leukemia睾丸白血病3 c- w( ?- C/ _% M
TLI:total Lymphoid irradiation,全淋巴照射
6 U/ v% a, ]4 P" X. pThrombotic microangiopathy (TMA):血栓性微血管病
. M' u1 q8 V/ h; j, q8 Q0 QTNF:tumor necrosis factor,肿瘤坏死因子
, a, p9 Z% c# U/ w) E, }" tTNI:total nodal irradiation,全淋巴结照射. k# P' R8 f; N' o
TOPO II:topoisomerase II,拓扑易构酶II2 o. v7 i+ k/ f
Toxin:毒素 - R. D5 J9 S C
Tpdt:potential doubling time,倍增时间, r, n+ T" g* Q/ m3 m5 T; @
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病8 ~/ e0 G7 o3 Y! y8 }' _. Q
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
3 v6 C" @7 p1 y/ ~: ^TPO:thrombopoietin,促血小板生成素: h1 l n5 B/ C( S
TPS:treatment planning system,治疗计划系统
|; T. I/ F/ [- y6 N% S& DTranslocation:易位6 G* b0 l* V T- w1 P5 O# X
Trauma:创伤
# f$ J X( u7 k3 a. S- S- U, ETRM:transplantation related mortality,移植相关死亡率+ F \; f/ Y# o: {: C
TSC:timed-sequential chemotherapy,时相序贯化疗8 B5 a9 ?0 }+ z' o
TSPA:triophosphoramide,噻替派6 n* T6 U: l8 \
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜' p" A1 _; C4 q( l; g( m) J
Tumor:肿瘤 : E% |* v6 q1 L8 Y0 P) S* d
Tumor burden:肿瘤负荷 / U2 H9 P: B' h$ a7 p
UCB:umbilical cord blood,脐带血
7 e) f: j3 ]0 }1 t; r' ~! t3 z! wUltrasound:超声 0 r, z+ z, o! S
Umbilical cord:脐带$ W- C6 k* g/ u) _
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
) \7 ^9 `# {, k: |! Y8 j) SVGPR:very good partial remission,非常良好的部分缓解
1 ?2 |$ u' q& g) M! z( F2 \; IViability:活性5 \9 w/ p5 g, m- k* m
Virus:病毒
& l) O4 W- x- P2 |& CVOD:veno-occlusive disease,静脉阻塞性疾病
. ~* F) }) y7 Q4 R3 f e4 D. S! Dv-onc: virus oncogene,病毒癌基因
& n' I# @ S9 aVPF: vascular permeability factor,血管渗透因子
" q6 k1 E0 j5 m6 JVZV:varicella zoster virus,水痘带状疱疹病毒
- M! }* N8 P) e4 B DWBC:white blood cell,白细胞
3 O5 R" [9 F0 |5 F* _Whole blood:全血 : {' ?" ~. M. C
WT:Wilms tumor,肾母细胞瘤) E# J _0 W# c6 b4 Q
Xerostomia:口腔干燥症 $ Z( X6 F3 c. `
Yield:产量 |
|